Note to users. If you're seeing this message, it means that your browser cannot find this page's style/presentation instructions -- or possibly that you are using a browser that does not support current Web standards. Find out more about why this message is appearing, and what you can do to make your experience of our site the best it can be.

Site Tools

  • AAAS
  • Subscribe
  • Feedback

Site Search

Search Advanced

Science 25 April 1986:
Vol. 232. no. 4749, pp. 511 - 512
DOI: 10.1126/science.3008329

Articles

Science, Vol 232, Issue 4749, 511-512
Copyright © 1986 by American Association for the Advancement of Science


articles

Receptor-associated resistance to growth hormone-releasing factor in dwarf "little" mice

JO Jansson, TR Downs, WG Beamer, and LA Frohman

Anterior pituitaries from the dwarf mouse strain "little" did not release growth hormone or accumulate adenosine 3',5'-monophosphate (cyclic AMP) in response to human and rat growth hormone-releasing factor (GRF). Dibutyryl cyclic AMP, as well as the adenylate cyclase stimulators forskolin and cholera toxin, markedly stimulated growth hormone (GH) release. The basis of the GH deficiency in the little mouse may therefore be a defect in an early stage of GRF-stimulated GH release related either to receptor binding or to the function of the hormone-receptor complex.


THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES:
Conditional Deletion of Insulin-like Growth Factor-I Receptor in Prostate Epithelium.
B. W. Sutherland, S. E. Knoblaugh, P. J. Kaplan-Lefko, F. Wang, M. Holzenberger, and N. M. Greenberg (2008)
Cancer Res. 68, 3495-3504
   Abstract »    Full Text »    PDF »
Endocrine Regulation of Gender-Divergent Mouse Organic Anion-Transporting Polypeptide (Oatp) Expression.
X. Cheng, J. Maher, H. Lu, and C. D. Klaassen (2006)
Mol. Pharmacol. 70, 1291-1297
   Abstract »    Full Text »    PDF »
Physiological Studies of Transgenic Mice Overexpressing Growth Hormone (GH) Secretagogue Receptor 1A in GH-Releasing Hormone Neurons.
S. Lall, N. Balthasar, D. Carmignac, C. Magoulas, A. Sesay, P. Houston, K. Mathers, and I. Robinson (2004)
Endocrinology 145, 1602-1611
   Abstract »    Full Text »    PDF »
Regulation of Mouse Renal CYP2J5 Expression by Sex Hormones.
J. Ma, J. Graves, J. A. Bradbury, Y. Zhao, D. L. Swope, L. King, W. Qu, J. Clark, P. Myers, V. Walker, et al. (2004)
Mol. Pharmacol. 65, 730-743
   Abstract »    Full Text »    PDF »
Pitx2 is required at multiple stages of pituitary organogenesis: pituitary primordium formation and cell specification.
H. Suh, P. J. Gage, J. Drouin, and S. A. Camper (2003)
Development 129, 329-337
   Abstract »    Full Text »    PDF »
The little mutation suppresses DEN-induced hepatocarcinogenesis in mice and abrogates genetic and hormonal modulation of susceptibility.
J. M. Bugni, T. M. Poole, and N. R. Drinkwater (2001)
Carcinogenesis 22, 1853-1862
   Abstract »    Full Text »    PDF »
Induction of Mammary Gland Development in Estrogen Receptor-{alpha} Knockout Mice.
W. P. Bocchinfuso, J. K. Lindzey, S. C. Hewitt, J. A. Clark, P. H. Myers, R. Cooper, and K. S. Korach (2000)
Endocrinology 141, 2982-2994
   Abstract »    Full Text »    PDF »
The Mutant Growth Hormone-Releasing Hormone (GHRH) Receptor of the Little Mouse Does Not Bind GHRH.
B. D. Gaylinn, V. I. DeAlmeida, C. E. Lyons Jr., K. C. Wu, K. E. Mayo, and M. O. Thorner (1999)
Endocrinology 140, 5066-5074
   Abstract »    Full Text »
Growth Hormone (GH)-Releasing Hormone (GHRH) and the GH Secretagogue (GHS), L692,585, Differentially Modulate Rat Pituitary GHS Receptor and GHRH Receptor Messenger Ribonucleic Acid Levels.
R. D. Kineman, J. Kamegai, and L. A. Frohman (1999)
Endocrinology 140, 3581-3586
   Abstract »    Full Text »
Familial Dwarfism due to a Novel Mutation of the Growth Hormone-Releasing Hormone Receptor Gene.
R. Salvatori, C. Y. Hayashida, M. H. Aguiar-Oliveira, J. A. Phillips III, A. H. O. Souza, R. G. Gondo, S. P. A. Toledo, M. M. Conceicão, M. Prince, H. G. Maheshwari, et al. (1999)
J. Clin. Endocrinol. Metab. 84, 917-923
   Abstract »    Full Text »
Selective Lack of Growth Hormone (GH) Response to the GH-Releasing Peptide Hexarelin in Patients with GH-Releasing Hormone Receptor Deficiency.
H. G. Maheshwari, A. Rahim, S. M. Shalet, and G. Baumann (1999)
J. Clin. Endocrinol. Metab. 84, 956-959
   Abstract »    Full Text »
Growth Hormone (GH)-Releasing Peptide-6 Requires Endogenous Hypothalamic GH-Releasing Hormone for Maximal GH Stimulation.
N. Pandya, R. DeMott-Friberg, C. Y. Bowers, A. L. Barkan, and C. A. Jaffe (1998)
J. Clin. Endocrinol. Metab. 83, 1186-1189
   Abstract »    Full Text »
Hypothalamic Growth Hormone Secretagogue-Receptor (GHS-R) Expression Is Regulated by Growth Hormone in the Rat.
P. A. Bennett, G. B. Thomas, A. D. Howard, S. D. Feighner, L. H. T. Van der Ploeg, R. G. Smith, and I. C. A. F. Robinson (1997)
Endocrinology 138, 4552-4557
   Abstract »    Full Text »    PDF »
Peptidomimetic Regulation of Growth Hormone Secretion.
R. G. Smith, L. H. T. Van der Ploeg, A. D. Howard, S. D. Feighner, K. Cheng, G. J. Hickey, M. J. Wyvratt Jr., M. H. Fisher, R. P. Nargund, and A. A. Patchett (1997)
Endocr. Rev. 18, 621-645
   Abstract »    Full Text »
Effects of Growth Hormone Secretagogues in the Transgenic Growth-Retarded (Tgr) Rat.
T. Wells, D. M. Flavell, S. E. Wells, D. F. Carmignac, and I. C. A. F. Robinson (1997)
Endocrinology 138, 580-587
   Abstract »    Full Text »    PDF »
Dwarf mice produced by genetic ablation of growth hormone-expressing cells..
R R Behringer, L S Mathews, R D Palmiter, and R L Brinster (1988)
Genes & Dev. 2, 453-461
   Abstract »    PDF »



To Advertise     Find Products


Science. ISSN 0036-8075 (print), 1095-9203 (online)